We present a sensitive tracer method, suitable for in vivo human research, that uses  -[ 14 C]carotene coupled with accelerator mass spectrometry (AMS) detection. Using this approach, the concentration-time course of a physiological (306 g; 200 nCi) oral dose of  -[ 14 C]carotene was determined for 209 days in plasma. Analytes included  -[ 14 C]carotene, [ 14 C]retinyl esters, [ 14 C]retinol, and several [ 14 C]retinoic acids. There was a 5.5-h lag between dosing and the appearance of 14 C in plasma. Labeled  -carotene and [ 14 C]retinyl esters rose and displayed several maxima with virtually identical kinetic profiles over the first 24-h period; elevated [ 14 C]retinyl ester concentrations were sustained in the plasma compartment for Ͼ 21 h postdosing. The appearance of [ 14 C]retinol in plasma was also delayed 5.5 h postdosing and its concentration rose linearly for 28 h before declining. Cumulative urine and stool were collected for 17 and 10 days, respectively, and 57.4% of the dose was recovered in the stool within 48 h postdosing. The stool was the major excretion route for the absorbed dose. The turnover times (1/k el ) for  -carotene and retinol were 58 and 302 days, respectively. Area under the curve analysis of the plasma response curves suggested a molar vitamin A value of 0.53 for  -carotene, with a minimum of 62% of the absorbed  -carotene being cleaved to vitamin A.In summary, AMS is an excellent tool for defining the in vivo metabolic behavior of  -carotene and related compounds at physiological concentrations. Further, our data suggest that retinyl esters derived from  -carotene may undergo hepatic resecretion with VLDL in a process similar to that observed for  -carotene. -